Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1965 Nov;103(5):305–309.

Chemical Approaches to Selective Inhibition of Viral Multiplication

Igor Tamm, Hans J Eggers
PMCID: PMC1516049  PMID: 5834271

Abstract

There are more than 300 immunological types of viruses that infect man, but most are members of only eight major groups, each group characterized by distinguishing physical and chemical features. Chemical inhibitors have been discovered which are selectively directed against members of individual groups of viruses. These inhibitors interfere with virus-specific processes and have no effects on host cell metabolism at concentrations sufficient to prevent or stop virus multiplication. The biochemical basis of such selective action is understood in some cases. In addition, synthetic chemicals and biological products are known that inhibit members of several groups of viruses. The basis of their selective action is not clear.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. APPLEYARD G., WESTWOOD J. C., ZWARTOUW H. T. The toxic effect of rabbitpox virus in tissue culture. Virology. 1962 Oct;18:159–169. doi: 10.1016/0042-6822(62)90001-6. [DOI] [PubMed] [Google Scholar]
  2. BALTIMORE D., EGGERS H. J., FRANKLIN R. M., TAMM I. Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production. Proc Natl Acad Sci U S A. 1963 Jun;49:843–849. doi: 10.1073/pnas.49.6.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BAUER D. J., SADLER P. W. The structure-activity relationships of the antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone. Br J Pharmacol Chemother. 1960 Mar;15:101–110. doi: 10.1111/j.1476-5381.1960.tb01216.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BAUER D. J., STVINCENT L., KEMPE C. H., DOWNIE A. W. PROPHYLACTIC TREATMENT OF SMALL POX CONTACTS WITH N-METHYLISATIN BETA-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN). Lancet. 1963 Sep 7;2(7306):494–496. doi: 10.1016/s0140-6736(63)90230-7. [DOI] [PubMed] [Google Scholar]
  5. CALABRESI P., McCOLLUM R. W., WELCH A. D. Suppression of infections resulting from a deoxyribonucleic acid virus (vaccinia) by systemic adminstration of 5-iodo-2'-deoxyuridine. Nature. 1963 Feb 23;197:767–769. doi: 10.1038/197767a0. [DOI] [PubMed] [Google Scholar]
  6. CHEONG L., RICH M. A., EIDINOFF M. L. Introduction of the 5-halogenated uracil moiety into deoxyribonucleic acid of mammalian cells in culture. J Biol Chem. 1960 May;235:1441–1447. [PubMed] [Google Scholar]
  7. CROWTHER D., MELNICK J. L. Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology. 1961 Sep;15:65–74. doi: 10.1016/0042-6822(61)90078-2. [DOI] [PubMed] [Google Scholar]
  8. Cohen S. S., Flaks J. G., Barner H. D., Loeb M. R., Lichtenstein J. THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES. Proc Natl Acad Sci U S A. 1958 Oct 15;44(10):1004–1012. doi: 10.1073/pnas.44.10.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DAVIES W. L., GRUNERT R. R., HAFF R. F., MCGAHEN J. W., NEUMAYER E. M., PAULSHOCK M., WATTS J. C., WOOD T. R., HERMANN E. C., HOFFMANN C. E. ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). Science. 1964 May 15;144(3620):862–863. doi: 10.1126/science.144.3620.862. [DOI] [PubMed] [Google Scholar]
  10. DELAMORE I. W., PRUSOFF W. H. Effect of 5-iodo-2'-deoxyuridine on the biosynthesis of phosphorylated derivatives of thymidine. Biochem Pharmacol. 1962 Feb;11:101–112. doi: 10.1016/0006-2952(62)90097-7. [DOI] [PubMed] [Google Scholar]
  11. EASTERBROOK K. B. Interference with the maturation of vaccinia virus by isatin beta-thiosemicarbazone. Virology. 1962 Jun;17:245–251. doi: 10.1016/0042-6822(62)90114-9. [DOI] [PubMed] [Google Scholar]
  12. EGGERS H. J., REICH E., TAMM I. THE DRUG-REQUIRING PHASE IN THE GROWTH OF DRUG-DEPENDENT ENTEROVIRUSES. Proc Natl Acad Sci U S A. 1963 Aug;50:183–190. doi: 10.1073/pnas.50.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. EGGERS H. J., TAMM I. 2,(alpha-hydroxybenzyl)-benzimidazole (HBB) as an aid in virus classification. Virology. 1961 Apr;13:545–546. doi: 10.1016/0042-6822(61)90285-9. [DOI] [PubMed] [Google Scholar]
  14. EGGERS H. J., TAMM I. SYNERGISTIC EFFECT OF 2-(ALPHA-HYDROXYBENZYL)-BENZIMIDAZOLE AND GUANIDINE ON PICORNAVIRUS REPRODUCTION. Nature. 1963 Aug 3;199:513–514. doi: 10.1038/199513b0. [DOI] [PubMed] [Google Scholar]
  15. EGGERS H. J., TAMM I. Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole. J Exp Med. 1961 Apr 1;113:657–682. doi: 10.1084/jem.113.4.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. EIDINOFF M. L., CHEONG L., RICH M. A. Incorporation of unnatural pyrimidine bases into deoxyribonucleic acid of mammalian cells. Science. 1959 Jun 5;129(3362):1550–1551. doi: 10.1126/science.129.3362.1550. [DOI] [PubMed] [Google Scholar]
  17. GREEN M. CHEMISTRY AND STRUCTURE OF ANIMAL VIRUS PARTICLES. Am J Med. 1965 May;38:651–668. doi: 10.1016/0002-9343(65)90188-9. [DOI] [PubMed] [Google Scholar]
  18. KADIN S. B., EGGERS H. J., TAMM I. SYNTHESIS AND VIRUS-INHIBITORY ACTIVITY OF D- AND L-ISOMERS OF 2-(ALPHA-HYDROXY-BENZYL)-BENZIMIDAZOLE. Nature. 1964 Feb 8;201:639–640. doi: 10.1038/201639a0. [DOI] [PubMed] [Google Scholar]
  19. KAUFMAN H., MARTOLA E. L., DOHLMAN C. Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis. Arch Ophthalmol. 1962 Aug;68:235–239. doi: 10.1001/archopht.1962.00960030239015. [DOI] [PubMed] [Google Scholar]
  20. LODDO B., FERRARI W., SPANEDDA A., BROTZU G. In vitro guanidino-resistance and guanidino-dependence of poliovirus. Experientia. 1962 Nov 15;18:518–519. doi: 10.1007/BF02151608. [DOI] [PubMed] [Google Scholar]
  21. MATHIAS A. P., FISCHER G. A., PRUSOFF W. H. Inhibition of the growth of mouse leukemia cells in culture by 5-iododeoxyuridine. Biochim Biophys Acta. 1959 Dec;36:560–561. doi: 10.1016/0006-3002(59)90209-4. [DOI] [PubMed] [Google Scholar]
  22. MELNICK J. L., CROWTHER D., BARRERA-ORO J. Rapid development of drug-resistant mutants of poliovirus. Science. 1961 Aug 25;134(3478):557–557. doi: 10.1126/science.134.3478.557. [DOI] [PubMed] [Google Scholar]
  23. PRUSOFF W. H., BAKHLE Y. S., MCCREA J. F. INCORPORATION OF 5-IODO-2'-DEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF VACCINIA VIRUS. Nature. 1963 Sep 28;199:1310–1311. doi: 10.1038/1991310a0. [DOI] [PubMed] [Google Scholar]
  24. PRUSOFF W. H. Incorporation of iododeoxyuridine into the deoxyribonucleic acid of mouse Ehrlich-ascites-tumor cells in vivo. Biochim Biophys Acta. 1960 Apr 8;39:327–331. doi: 10.1016/0006-3002(60)90170-0. [DOI] [PubMed] [Google Scholar]
  25. TAMM I., EGGERS H. J. Differences in the selective virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine HCl. Virology. 1962 Nov;18:439–447. doi: 10.1016/0042-6822(62)90034-x. [DOI] [PubMed] [Google Scholar]
  26. TAMM I., EGGERS H. J. SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES. Science. 1963 Oct 4;142(3588):24–33. doi: 10.1126/science.142.3588.24. [DOI] [PubMed] [Google Scholar]
  27. THOMPSON R. L., MINTON S. A., Jr, OFFICER J. E., HITCHINGS G. H. Effect of heterocyclic and other thiosemicarbazones on vaccinia infection in the mouse. J Immunol. 1953 Mar;70(3):229–234. [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES